Treating methamphetamine abuse disorder: Experience from research and practice
As prevalence of methamphetamine abuse mushrooms, practitioners face the challenge of treating the disorder, its withdrawal symptoms, and stimulant-induced psychosis
Related Resources
• Karch SB, Drummer O. Karch’s pathology of drug abuse, fifth ed. Boca Raton, FL: CRC Press/Taylor & David; 2013.
• Roll J, Rawson RA, Ling W, eds. Methamphetamine addiction: from basic science to treatment. New York, NY: Guilford Press; 2009.
• Sheff D. Beautiful boy: a father’s journey through his son’s addiction. New York, NY: Houghton Mifflin Harcourt Publishing Company; 2008.
• Sheff N. Tweak: growing up on methamphetamines. New York, NY: Antheneum Books for Young Readers; 2007.
• National Institute on Drug Abuse. Drugs of abuse. www. drugabuse.gov/drugs-abuse/methamphetamine.
Drug Brand Names
Baclofen • Lioresal Naltrexone (depot) • Vivitrol
Bupropion • Wellbutrin Naltrexone (oral) • ReVia
D-cycloserine • Seromycin Ondansetron • Zofran
Dexreoamphetaime • Adderall Risperidone • Risperadal
Disulfiram • Antabuse Rivastigimine • Exelon
Gabapentin • Neurontin Selegiline• EMSAM
Methylphenidate • Ritalin Sertraline • Zoloft
Mirtazapine • Remeron Topiramate • Topamax
Modafinil • Provigil Varenicline • Chantix
N-acetylcysteine • Mucomyst Vigabatrin • Sabril
Disclosures
The authors report no financial relationships with any company whose products are mentioned in this article or with manufacturers of competing products.
